Mount Sinai researchers developed a first-in-class cell-selective modRNA translation system that turns therapeutic genes on ...

Aside from maybe high school biology classes, the first time many people heard of mRNA was during the pandemic because of the ...

Researchers developed cSMRTS, an engineered mRNA that preferentially turns on therapeutic genes inside targeted cells, shown ...

SMRTS, a smart mRNA system, enables cell‑selective gene expression, expanding the mRNA toolbox for precision cancer therapies.

RNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the ...

BioNTech, founded in 2008 in Germany, has become a key player in the development of personalized mRNA cancer treatments. The emerging biotech's first commercial vaccine, for COVID-19, received its ...

KAIST researchers have developed a method that attaches DNA fragments to mRNA to slow the onset of protein production, ...

The research, published in Science Translational Medicine, found that messenger RNA (mRNA) could be used to correct a rare liver genetic disease known as argininosuccinic aciduria in a mouse model of ...

NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...

A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after COVID-19 mRNA vaccination, ...